Vital Strategies Tobacco Cessation Grant Round Risks Philanthropic Colonialism, CAPHRA Warns

WELLINGTON, New Zealand - July 13, 2026 - PRLog -- The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today warned that a new Bloomberg Philanthropies-funded grant round risks entrenching foreign influence over sovereign health policy across Asia Pacific.

The July 2026 strategic cessation grant round, managed by Vital Strategies under the Bloomberg Initiative to Reduce Tobacco Use, is open only to applicants in nine priority countries: India, Indonesia, Bangladesh, Pakistan, Vietnam, the Philippines, Brazil, Ukraine, and Mexico. It funds cessation services and MPOWER tobacco-control programmes for both government and NGO applicants.

Key concerns raised by CAPHRA:

• Donor-funded networks can shape regulatory institutions before genuine domestic debate occurs, a pattern CAPHRA describes as philanthropic colonialism.
• Prohibitionist models promoted through donor-aligned technical assistance risk pushing consumers toward illegal, unregulated markets.
• Excluding safer nicotine alternatives leaves smokers reliant on combustible cigarettes, still the region's leading cause of preventable death.
• WHO FCTC tobacco-control spaces risk becoming dependent on a narrow, billionaire-funded policy network that excludes consumer and independent harm reduction voices.

Nancy Loucas, Executive Coordinator of CAPHRA, said the issue is not whether countries should reduce smoking, but whether governments retain the right to choose their own path.

"Sovereign health policy should not be written by donor networks," Loucas said. "Governments can cooperate internationally without outsourcing their nicotine policy to billionaire-funded advocacy systems."

Loucas added: "Public health loses legitimacy when policy begins to look outsourced. If WHO-linked tobacco-control spaces are dominated by billionaire-funded organisations, while consumers and independent harm reduction voices remain excluded, governments have every reason to ask whether the system is still serving public health or serving wealthy donors."

CAPHRA is calling on Asia Pacific governments to:

• Assert full policy sovereignty over national nicotine and tobacco regulation
• Publish all foreign-funded tobacco-control partnerships and grant agreements
• Disclose technical assistance relationships and donor-funded policy contributors
• Separate grant dependence from regulatory decision-making
• Assess the full evidence base, including safer nicotine alternatives, before adopting donor-approved frameworks

"At stake is more than one grant programme," Loucas said. "It is whether sovereign states remain in charge of their own public health strategy."

About CAPHRA (http://www.caphraorg.net)

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is a regional network of consumer and harm reduction advocacy organisations representing millions of tobacco harm reduction consumers across Asia Pacific. CAPHRA advocates for evidence-based nicotine policy, consumer participation in regulatory processes, and national policy sovereignty free from undue donor influence.